Combo treatment delays multiple myeloma progression and may improve survival, study finds
MedicalXpress
|
六月 15, 2026
Patients with multiple myeloma who received a new immunotherapy combination lived significantly longer without their cancer worsening and showed early signs of improved survival in a large international clinical trial.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗